Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by LithLoveron Jun 17, 2021 5:24pm
165 Views
Post# 33408604

RE:Things are HEATING UP!

RE:Things are HEATING UP!Hmmm

Whether it’s an Annual Meeting or Special Meeting our program scope can be a simple ProxyGUARD® service or a comprehensive Proxy Solicitation program including call campaigns for shareholder voting outreach. This unique, customizable approach is what sets Laurel Hill apart from the competition. It allows us to focus solely on our client’s best interest for a successful outcome.

With offices in the U.S. and Canada, Laurel Hill is the only independent, cross border advisory firm with a growing portfolio of Fortune 500 companies on both sides of the border as well as Micro Cap and Small Cap issuers.
 

gojotv! wrote: I got a call from Laurel Hill Advisory, a top firm, to check up on my votes. That's never happened in my years as a shareholder.
Clearly, SZLS is now aware of its quickly-growing importance and is positioning itself with some top players.
Aristotle must have gone over well with Care Oncology's established patient base, and with that contractual obligation adressed, it's now being released to the broader market!
No wonder they've had to hire more people!
With Covid testing in more and more Fortune 500 companies and Aristotle out of the gate, they must be very busy! Q2 is going to have some nice surprises for us.
If I were a basher, I would have been all over the boards today, too!
Look for a squeeze tomorrow and next week.
Glad I already have my shares!
GLTA!




<< Previous
Bullboard Posts
Next >>